home / lobbying / lobbying_activities

lobbying_activities: 2102507

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2102507 a31e9579-befa-4e13-8edc-29120d4b4892 Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2018 first_quarter HCR H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to access to and affordability of prescription medications and inclusion of tools to fight the opioid epidemic. H.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related to access to and affordability of prescription medications and policies and resources to fight the opioid crisis in the United States. CMS regulations related to the Medicare Part D program and role of Prescription Drug Plans. S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. H.R. 281- National Defense Authorization Act for FY 2018- Issues related to prescription medications for military personnel and their families. H.R. 3447 - Furthering Access to Coordinated Treatment for Seniors (FACTS) Act of 2017 - Working to explain the need for safe and confidential data sharing between Medicare part A, B, and D to ensure better coordination of patient care. Issues related to Direct and Indirect Renumeration policies and their impact on consumers. Issues related to the price of prescription medications in the United States. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2018-04-06T14:05:22.117000-04:00
Powered by Datasette · Queries took 15.143ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API